查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974192

微量採樣設備市場：按產品類型、樣品類型、最終用戶和分銷管道分類 - 2026-2032年全球預測

Microsampling Devices Market by Product Type, Sample Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年微採樣設備市場價值為 1.0615 億美元，預計到 2026 年將成長至 1.1634 億美元，複合年成長率為 7.49%，到 2032 年將達到 1.7603 億美元。

主要市場統計數據
基準年 2025 1.0615億美元
預計年份：2026年 1.1634億美元
預測年份 2032 1.7603億美元
複合年成長率 (%) 7.49%

不斷發展的微量採樣技術和分散式照護模式如何改變檢體採集方式並重新定義臨床和診斷工作流程。

微量採樣技術已從一項小眾的實驗室新技術發展成為一種實用工具，徹底改變了臨床研究、診斷和分散式醫療服務中的檢體採集模式。過去十年間，毛細管採樣光學、乾血斑穩定化、微流體晶片工程和體積吸收微量採樣等的技術進步，降低了對傳統靜脈穿刺和集中處理的依賴。這種轉變為遠端患者監護、簡化檢體物流以及以患者為中心的試驗設計開闢了新的途徑。

以使用者為中心的設計、數位化支援和監管規定的明確化，使得微量採樣從先導計畫發展成為綜合性的臨床和診斷實踐。

微量採樣領域經歷了變革性的轉變，這主要得益於技術創新、醫療服務模式的變革以及對病患​​體驗日益成長的關注。儀器和耗材供應商致力於透過改進設計來降低分析前變異性，從而控制體積精度、減少血球比容的影響並提高檢體均一性。同時，微流體晶片設計的進步使得以往需要手動檢體處理步驟得以整合，從而拓展了微量樣本在更複雜檢測中的效用。

美國關稅趨勢變化對微量採樣設備及耗材製造商和經銷商的供應鏈、採購和生產決策的影響。

美國近期關稅政策的變化為生產和銷售微量採樣設備及相關耗材的公司帶來了更多挑戰。醫療設備和檢測設備組件的進口關稅結構和分類指南的調整，正在影響依賴跨境供應鏈的供應商的成本基礎，尤其是在精密組件、聚合物和特殊試劑領域。這些調整迫使採購部門重新評估其籌資策略和庫存管理政策，以維持利潤率和服務水準。

透過細分市場分析，明確對產品、通路和最終用戶的影響，從而指導微抽樣解決方案整體的策略優先排序和部署策略。

詳細的細分分析揭示了設備和通道配置中臨床效用、推廣障礙和商業性機會的交匯點。按樣本類型（毛細管採樣、乾血斑、微流體晶片、體積吸收微採樣）進行的市場分析表明，每種方法都有其獨特的分析相容性和用戶體驗方面的考慮。在微流體晶片子類別中，自動化取樣解決方案和實驗室晶片結構之間的差異凸顯了處理能力和照護現場適用性之間的權衡。同樣，在體積吸收微採樣方案中，諸如Capitainer、HemaXis和Mitra等平台特定的實現方式在儀器依賴性、使用者訓練要求和分析物穩定性方面也表現出不同的特性。

影響微採樣技術的商業化、檢驗和運作準備的區域產品、監管和分銷要求。

區域趨勢對產品設計選擇、監管準備和商業性市場進入策略有顯著影響。在美洲，對分散式臨床試驗的日益重視以及居家醫療基礎設施的擴展，推動了對使用者友善採樣方法和能夠管理分散式採集點的強大物流解決方案的需求。該地區的監管路徑也在不斷發展，以適應替代基質和遠端採樣，這影響供應商建構檢驗方案和客戶支援服務的方式。

競爭格局洞察重點在於設備精度、檢驗夥伴關係以及服務豐富的商業模式，這些因素會影響供應商的選擇和部署速度。

微量採樣生態系統的競爭動態呈現出多元化的態勢，既有專注於設備創新的專業廠商，也有不斷拓展產品線的大型診斷公司，還有檢驗和標準化工作流程的合約實驗室。產品差異化通常體現在採樣量精度、血球容積比降低策略、使用者人體工學設計、與檢查室自動化系統的整合能力等。能夠提供卓越易用性、清晰的分析效能和可靠的檢驗數據的公司往往更受臨床和科學研究客戶的青睞。

要將微抽樣技術的潛力轉化為永續的應用，實際的策略重點必須包括產品設計和檢驗的嚴謹性、供應鏈的韌性以及通路的執行。

評估策略方案的領導者應著重採取切實可行的步驟，使產品開發、監管策略和商業性執行與實際部署限制相符。優先投資於可用性測試和人體工學，減輕訓練負擔，並確保可靠的患者主導型檢體採集。將這些努力與嚴謹的方法檢驗研究和透明的文件結合，可以縮短診斷實驗室和臨床申辦者的引進週期。

本研究旨在透過嚴格整合一手訪談、技術文獻、監管指南和營運案例研究，產生可重複的決策見解。

本研究整合了訪談資料、技術文獻、監管指南和營運案例研究，全面展現了微量採樣技術的現況。主要資料來源包括對醫療機構和生命科學公司的實驗室經理、臨床營運經理、居家照護專案經理和採購專業人員的結構化訪談。這些訪談內容深入觀點了可用性挑戰、整合需求和檢驗重點，是技術性能數據的補充。

技術成熟度、營運準備情況以及協作檢驗的整合是決定微採樣解決方案長期臨床接受度和部署的關鍵因素。

微量採樣技術正處於一個十字路口，技術成熟度、分散式醫療的發展趨勢以及實際操作的可行性在此交匯融合。設備性能和微流體整合技術的不斷進步拓展了毛細管採樣和體積檢測法的應用場景。同時，使用者支援和訓練的改進降低了患者輔助採集檢體的門檻。然而，隨著關稅和物流趨勢對成本和供應鏈的影響，分銷網路和供應鏈的韌性變得日益重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：微量採樣設備市場：依產品類型分類

  • 配件
  • 消耗品
  • 裝置
  • 成套工具

第9章：依樣品類型分類的微量取樣設備市場

  • 毛細管採樣
  • 乾血斑
  • 微流體晶片
    • 自動採樣裝置
    • 晶片實驗室
  • 體積吸收微量取樣
    • 資本家
    • 血軸
    • 米特拉

第10章：微量採樣設備市場：依最終用戶分類

  • CRO（受託研究機構）
  • 診斷檢查室
  • 居家醫療
  • 醫院
  • 製藥公司
  • 研究機構

第11章：微量採樣設備市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 線上管道

第12章 微量採樣設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 微量採樣設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 微量採樣設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國微量採樣設備市場

第16章：中國微量採樣設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • AptarGroup, Inc.
  • Bio-Rad Laboratories, Inc.
  • Capitainer AB
  • Cardinal Health, Inc.
  • HemaXis
  • HTL-STREFA SA
  • LGC Limited
  • Medtronic plc
  • Merck KGaA
  • Neoteryx LLC
  • Nipro Corporation
  • Owen Mumford Ltd.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Sarstedt AG & Co. KG
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Spot On Sciences, Inc.
  • Tasso, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Trajan Scientific and Medical Pty Ltd
  • West Pharmaceutical Services, Inc.
Product Code: MRR-D97D8E0B50BE

The Microsampling Devices Market was valued at USD 106.15 million in 2025 and is projected to grow to USD 116.34 million in 2026, with a CAGR of 7.49%, reaching USD 176.03 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 106.15 million
Estimated Year [2026] USD 116.34 million
Forecast Year [2032] USD 176.03 million
CAGR (%) 7.49%

How evolving microsampling technologies and decentralized care models are shifting specimen collection practices and redefining clinical and diagnostic workflows

Microsampling technologies have evolved from niche laboratory curiosities into practical tools that are reshaping sample collection paradigms across clinical research, diagnostics, and decentralized care delivery. Over the past decade, technological refinements in capillary sampling optics, dried blood spot stabilization, microfluidic cartridge engineering, and volumetric absorptive microsampling have reduced reliance on traditional venipuncture and centralized processing. This transition has unlocked new pathways for remote patient monitoring, simplified specimen logistics, and more patient-centric trial designs.

Consequently, stakeholders across pharmaceutical development, diagnostic laboratories, and clinical care settings are reassessing their sample collection strategies to capture the clinical value of minimally invasive approaches. Adoption drivers include improved patient convenience, reduced cold-chain dependency for some analytes, and enhanced access to geographically dispersed cohorts. Importantly, these technologies are converging with digital health enablers-such as mobile apps for sample collection guidance and cloud-based data management-creating an ecosystem that supports scalable decentralized studies.

As the landscape matures, decision-makers must weigh operational trade-offs, including standardization of pre-analytical variables, integration with laboratory workflows, and regulatory alignment for new sample matrices. The introduction of automated samplers and lab-on-a-chip platforms is also shifting expectations for throughput and analytical fidelity, prompting laboratories and contract research organizations to evaluate their readiness for adoption. Looking ahead, the interplay between usability, assay compatibility, and regulatory confidence will determine which microsampling approaches achieve mainstream clinical acceptance.

The convergence of user-centric design, digital support, and regulatory clarity that has propelled microsampling from pilot projects into integrated clinical and diagnostic operations

The landscape for microsampling has experienced transformative shifts driven by technological innovation, shifting care delivery models, and an intensified focus on patient experience. Instrument and consumable suppliers have concentrated on reducing pre-analytical variability through design improvements that control volumetric accuracy, hematocrit effects, and sample homogeneity. Parallel advances in microfluidic cartridge design have enabled the integration of sample handling steps that were previously manual, expanding the utility of microsamples in more complex assays.

At the same time, healthcare delivery has decentralized: home-care services, telemedicine visits, and remote clinical trials have grown in importance, fostering demand for reliable, patient-operated sampling solutions. This demand has, in turn, catalyzed investments in educational resources, user-friendly packaging, and digital support that guide non-specialist users through collection. The net effect is a widening addressable application set for microsampling beyond simple screening and into longitudinal pharmacokinetic and therapeutic drug monitoring contexts.

Regulatory and reimbursement landscapes are also adapting, with authorities providing more detailed guidance on sample integrity and process validation for alternative matrices. Strategic partnerships between device manufacturers and analytical laboratories have become more frequent, and these collaborations are accelerating method transfer, validation exercises, and real-world usability studies. Together, these dynamics are elevating microsampling from proof-of-concept demonstrations to integrated elements of clinical and diagnostic workflows.

How evolving U.S. tariff dynamics are reshaping supply chain, sourcing and production decisions for manufacturers and distributors of microsampling devices and consumables

Recent tariff developments in the United States have introduced additional layers of complexity for companies that manufacture or distribute microsampling devices and associated consumables. Changes in import duty structures and classification guidance for medical devices and laboratory components affect cost bases for suppliers that rely on cross-border supply chains, particularly for precision parts, polymers, and specialty reagents. These adjustments have prompted procurement teams to reassess sourcing strategies and inventory policies to preserve margin and service levels.

Consequently, some firms have shifted toward nearshoring or establishing regional distribution and manufacturing partnerships to mitigate duty exposure and to reduce lead-time variability. These efforts are often accompanied by a reassessment of product architectures to minimize components subject to higher tariffs, and by renegotiations of commercial terms with suppliers and logistics providers. From an operational standpoint, supply chain contingency planning and enhanced visibility into supplier footprints have become priorities for organizations that require uninterrupted access to critical devices and consumables.

For buyers and end users, the tariff-induced cost dynamics underscore the need for rigorous total-cost-of-ownership analysis that accounts for duties, freight, inventory carrying, and potential quality control overheads arising from new sourcing relationships. Meanwhile, regulatory compliance and product registration timelines can influence where manufacturers prioritize localized production or warehousing. In sum, tariff shifts are encouraging a more deliberate alignment of commercial, regulatory, and supply chain strategies across the microsampling ecosystem.

Segment-specific analysis that clarifies product, channel, and end-user implications to guide strategic prioritization and adoption strategies across microsampling solutions

A granular view of segmentation reveals where clinical utility, adoption barriers, and commercial opportunity intersect across device and channel configurations. When the market is examined through sample-type distinctions-capillary sampling, dried blood spot, microfluidic cartridge, and volumetric absorptive microsampling-each approach presents unique analytical compatibility and user-experience considerations. Within the microfluidic cartridge subset, the divergence between automated sampler solutions and lab-on-a-chip architectures highlights trade-offs between throughput and point-of-care applicability. Similarly, among volumetric absorptive microsampling options, platform-specific implementations such as Capitainer, HemaXis, and Mitra reflect varying degrees of instrument dependence, user training requirements, and analyte stability profiles.

Assessing end users-contract research organizations, diagnostic laboratories, home care providers, hospitals, pharmaceutical companies, and research institutes-illuminates differences in adoption drivers and operational constraints. Contract research organizations and pharmaceutical companies tend to prioritize standardization and regulatory traceability to support multisite studies, whereas home care and point-of-care settings emphasize ease of use and patient instruction. Diagnostic laboratories and hospitals focus on integration with existing pre-analytical workflows and compatibility with downstream assays, while research institutes often value flexibility for experimental protocols.

Distribution channels-direct sales, distributors, and online channels-shape how solutions reach end users and influence service offerings such as training, validation support, and inventory management. Direct sales models enable deeper technical collaboration for customized deployments, distributors can provide regional reach and regulatory navigation, and online channels offer scalability for consumables and standardized kit offerings. Product-type segmentation across accessories, consumables, devices, and kits further clarifies commercial dynamics: accessories and consumables require high-frequency replenishment and logistics optimization, devices often represent capital investments with longer replacement cycles, and kits bundle components to simplify adoption in decentralized contexts. Understanding these interconnected segmentation layers is essential for designing go-to-market strategies and prioritizing product development trajectories.

Regionally differentiated product, regulatory and distribution imperatives that influence commercialization, validation and operational readiness for microsampling technologies

Regional dynamics significantly influence product design choices, regulatory preparation, and commercial go-to-market tactics. In the Americas, emphasis on decentralized clinical trials and a growing home-care infrastructure create demand for user-friendly sampling modalities and robust logistics solutions that can handle dispersed collection points. Regulatory pathways in the region are evolving to address alternative matrices and remote sampling, which in turn affects how suppliers structure validation packages and customer support offerings.

Across Europe, the Middle East & Africa, heterogeneous healthcare systems and diverse regulatory regimes necessitate adaptable market entry strategies. In some European markets, stringent laboratory accreditation requirements and centralized healthcare procurement demand rigorous method validation and strong local partnerships. Meanwhile, in parts of the Middle East & Africa, infrastructure constraints and variable access to cold-chain logistics shape the appeal of modalities that minimize sample fragility and simplify transport.

The Asia-Pacific region presents a combination of rapid adoption in urban centers and uneven capabilities across geographies. High-volume clinical trial activity and expanding diagnostic testing capacity in several countries have increased appetite for scalable microsampling solutions, while other markets require education and adaptation to local clinical workflows. Across all regions, successful commercialization depends on aligning device specifications with regional clinical practices, regulatory expectations, and distribution architectures that can ensure both availability and technical support.

Competitive landscape insights emphasizing differentiation in device precision, validation partnerships, and service-rich commercial models that influence vendor selection and adoption velocity

Competitive dynamics in the microsampling ecosystem reflect a mix of specialized device innovators, large diagnostics firms expanding portfolios, and contract testing laboratories that validate and standardize workflows. Product differentiation frequently centers on precision of volumetric capture, hematocrit mitigation strategies, user ergonomics, and integration capability with laboratory automation. Companies that combine strong usability with clear analytical performance and robust validation data tend to gain preference among clinical and research customers.

Strategic collaborations are common, with manufacturers partnering with clinical laboratories, pharmaceutical sponsors, and technology providers to accelerate validation and to build evidence for specific use cases. These partnerships help to close gaps in analytical validation and to create shared protocols that support wider adoption. In parallel, organizations investing in manufacturing redundancy and regulatory expertise are better positioned to respond to regional registration requirements and to offer shorter lead times to customers.

Investment patterns suggest that firms concentrating on modular platforms, scalable consumables supply chains, and service-oriented offerings-such as method transfer assistance and training programs-are establishing durable value propositions. For buyers, the vendor landscape requires careful due diligence around product lifecycle management, roadmap transparency, and the availability of post-sale technical support to ensure long-term operability and compliance with evolving laboratory standards.

Actionable strategic priorities for aligning product design, validation rigor, supply resilience and channel execution to convert microsampling potential into sustained adoption

Leaders evaluating strategic options should focus on practical steps that align product development, regulatory strategy, and commercial execution with real-world adoption constraints. Prioritize investments in usability testing and human factors engineering to reduce training overhead and to ensure reliable patient-collected samples. Coupling these efforts with rigorous method validation studies and transparent documentation will shorten adoption cycles among diagnostic laboratories and clinical sponsors.

Consider establishing regional manufacturing or distribution arrangements to mitigate duty exposure and to improve fulfillment responsiveness. Parallel investments in supply chain visibility tools and quality oversight will reduce the operational risk associated with complex, cross-border component sourcing. Commercial strategies should emphasize bundled solutions-devices with validated consumables and accessible technical support-to lower the barrier to adoption for hospitals, home-care providers, and decentralized trial operators.

Finally, pursue partnerships that accelerate evidence generation, such as collaborations with contract research organizations and research institutes to publish reliability and concordance data. These alliances provide credible third-party validation that can influence procurement committees and regulatory reviewers. By aligning product design, validation rigor, and channel support to user needs, industry leaders can convert the current momentum in microsampling into sustained clinical and commercial adoption.

A rigorous synthesis of primary interviews, technical literature, regulatory guidance and operational case studies designed to produce reproducible, decision-ready insights

This research synthesizes primary interviews, technical literature, regulatory guidance, and operational case studies to construct a comprehensive picture of the microsampling landscape. Primary inputs include structured interviews with laboratory directors, clinical operations leads, home-care program managers, and procurement specialists across healthcare and life-science organizations. These voices provide perspective on usability challenges, integration needs, and validation priorities that complement technical performance data.

Secondary sources include peer-reviewed publications, standards documents, and methodological white papers that describe assay compatibility, pre-analytical considerations, and device engineering principles. The synthesis emphasizes cross-validation among multiple information sources to reduce bias and to ensure that findings reflect consistent patterns rather than isolated anecdotes. Analytical methods prioritize qualitative triangulation, scenario-based impact assessment, and vendor capability mapping to identify robust strategic insights.

Throughout the research process, attention was paid to ensuring reproducibility of validation claims and to clarifying regulatory expectations in principal jurisdictions. The methodology also incorporated a review of supply chain configurations and tariff implications to capture operational realities that can influence time-to-deployment. Together, these methods provide a balanced, practice-oriented foundation for the conclusions and recommendations presented.

Synthesis of technological maturity, operational readiness and collaborative validation that will determine long-term clinical acceptance and deployment of microsampling solutions

Microsampling is positioned at an inflection point where technical maturity, decentralized care trends, and operational pragmatism intersect. The accumulated progress in device performance and microfluidic integration has expanded the practical use cases for capillary and volumetric approaches, while improvements in user support and training have reduced barriers to patient-collected sampling. At the same time, distribution networks and supply chain resilience carry increased importance as tariff and logistics dynamics influence cost and availability.

Stakeholders that align product development with rigorous validation, clear regulatory documentation, and targeted channel strategies will be best placed to capture the operational and clinical benefits of microsampling. Collaborative evidence generation remains a critical enabler, with partnerships between device developers, laboratories, and sponsors accelerating acceptance in clinical and diagnostic workflows. Ultimately, the future trajectory will be shaped by the degree to which the industry can standardize pre-analytical processes, demonstrate analytical equivalence where appropriate, and deliver consistent user experiences that translate into reliable specimens for downstream analytics.

In this environment, strategic clarity and operational discipline-rooted in validated performance and dependable supply arrangements-will determine which organizations convert early promise into long-term impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Microsampling Devices Market, by Product Type

  • 8.1. Accessories
  • 8.2. Consumables
  • 8.3. Devices
  • 8.4. Kits

9. Microsampling Devices Market, by Sample Type

  • 9.1. Capillary Sampling
  • 9.2. Dried Blood Spot
  • 9.3. Microfluidic Cartridge
    • 9.3.1. Automated Sampler
    • 9.3.2. Lab On A Chip
  • 9.4. Volumetric Absorptive Microsampling
    • 9.4.1. Capitainer
    • 9.4.2. HemaXis
    • 9.4.3. Mitra

10. Microsampling Devices Market, by End User

  • 10.1. Contract Research Organizations
  • 10.2. Diagnostic Laboratories
  • 10.3. Home Care
  • 10.4. Hospitals
  • 10.5. Pharmaceutical Companies
  • 10.6. Research Institutes

11. Microsampling Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Channels

12. Microsampling Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Microsampling Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Microsampling Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Microsampling Devices Market

16. China Microsampling Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. AptarGroup, Inc.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. Capitainer AB
  • 17.9. Cardinal Health, Inc.
  • 17.10. HemaXis
  • 17.11. HTL-STREFA S.A.
  • 17.12. LGC Limited
  • 17.13. Medtronic plc
  • 17.14. Merck KGaA
  • 17.15. Neoteryx LLC
  • 17.16. Nipro Corporation
  • 17.17. Owen Mumford Ltd.
  • 17.18. PerkinElmer, Inc.
  • 17.19. Phenomenex, Inc.
  • 17.20. Sarstedt AG & Co. KG
  • 17.21. Shimadzu Corporation
  • 17.22. Siemens Healthineers AG
  • 17.23. Spot On Sciences, Inc.
  • 17.24. Tasso, Inc.
  • 17.25. Terumo Corporation
  • 17.26. Thermo Fisher Scientific, Inc.
  • 17.27. Trajan Scientific and Medical Pty Ltd
  • 17.28. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MICROSAMPLING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MICROSAMPLING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 165. G7 MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 172. NATO MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)